Testing program launched in Najaf to detect genetic disorders in newborns

NAJAF — Medical teams in Najaf’s Al-Mishkhab district have launched a screening program to detect genetic and metabolic disorders in newborns aged between 72 hours to 30 days. The program involves collecting blood samples from the infant’s heel and sending them to the Central Health Laboratory in Najaf. The first three samples have already been registered under the program.

The program, which covers all newborns in the city and visiting families, aims to diagnose potential health problems early and provide appropriate treatment. Aqeel Hilal, Director of the Laboratory Unit at Al-Mishkhab Health Center, emphasized the importance of the program.

“We began implementing the screening program for newborns aged 3 to 30 days,” Hilal told 964media. “The objective is to detect genetic disorders and congenital abnormalities that may affect the child’s future health. These tests are crucial for early diagnosis and intervention.”

Hilal explained that the procedure involves drawing a small blood sample from the infant’s heel, which is then placed on a special card and transported to the Central Health Laboratory in Najaf. The tests screen for genetic conditions such as congenital abnormalities and thyroid diseases.

“In the past, we would only learn about a child’s condition after much time had passed,” Hilal said. “Now, we can diagnose and treat health issues early.”

Ammar Qaisar, Deputy Director of the Al-Mishkhab Health Center, noted that the program is gaining momentum due to cooperation from families.

“The first three samples were collected from children in Al-Mishkhab as part of the Najaf-wide program. The number of participants is steadily increasing, thanks to the support of the community,” Qaisar told 964media.

He added that Najaf is the third governorate to adopt the screening program after Baghdad and Karbala. Parents are informed of the results through the health center, and if an issue is detected, children are referred to specialists for immediate treatment to manage the condition early.

“We urge parents to participate in this vital program to protect their children from disabilities and health complications,” Qaisar said.